Challenges and advice for MD/PhD applicants who are underrepresented in medicine.
Journal
Molecular biology of the cell
ISSN: 1939-4586
Titre abrégé: Mol Biol Cell
Pays: United States
ID NLM: 9201390
Informations de publication
Date de publication:
15 11 2020
15 11 2020
Historique:
entrez:
12
11
2020
pubmed:
13
11
2020
medline:
14
7
2021
Statut:
ppublish
Résumé
The importance of diversity is self-evident in medicine and medical research. Not only does diversity result in more impactful scientific work, but diverse teams of researchers and clinicians are necessary to address health disparities and improve the health of underserved communities. MD/PhD programs serve an important role in training physician-scientists, so it is critical to ensure that MD/PhD students represent diverse backgrounds and experiences. Groups who are underrepresented in medicine and the biomedical sciences include individuals from certain racial and ethnic backgrounds, individuals with disabilities, individuals from disadvantaged backgrounds, and women. However, underrepresented students are routinely discouraged from applying to MD/PhD programs due to a range of factors. These factors include the significant cost of applying, which can be prohibitive for many students, the paucity of diverse mentors who share common experiences, as well as applicants' perceptions that there is inadequate support and inclusion from within MD/PhD programs. By providing advice to students who are underrepresented in medicine and describing steps programs can take to recruit and support minority applicants, we hope to encourage more students to consider the MD/PhD career path that will yield a more productive and equitable scientific and medical community.
Identifiants
pubmed: 33180675
doi: 10.1091/mbc.E20-07-0444
pmc: PMC7927183
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2640-2643Subventions
Organisme : NIGMS NIH HHS
ID : T32 GM008169
Pays : United States
Organisme : NIGMS NIH HHS
ID : T32 GM142617
Pays : United States
Références
J Infect Dis. 2019 Aug 20;220(220 Suppl 2):S33-S41
pubmed: 31430380
JAMA. 2019 Nov 26;322(20):2022-2024
pubmed: 31769816
Acad Med. 2017 May;92(5):628-634
pubmed: 28441673
J Gen Intern Med. 2005 Jul;20(7):565-71
pubmed: 16050848
Acad Med. 2017 Mar;92(3):365-369
pubmed: 27680316
Med Educ Online. 2016 May 13;21:30941
pubmed: 27189673
JCI Insight. 2019 Oct 3;4(19):
pubmed: 31578303
J Clin Invest. 2015 Oct 1;125(10):3742-7
pubmed: 26426074
MMWR Morb Mortal Wkly Rep. 2018 Aug 17;67(32):882-887
pubmed: 30114005
Acad Med. 2020 Mar;95(3):344-350
pubmed: 31425186
J Infect Dis. 2018 Aug 14;218(suppl_1):S40-S43
pubmed: 30124975
Acad Med. 2015 Jul;90(7):953-60
pubmed: 25629949
J Clin Invest. 2020 Jan 2;130(1):17-19
pubmed: 31815735
N Engl J Med. 2014 Mar 20;370(12):1083-5
pubmed: 24645940
Mil Med. 2015 Apr;180(4 Suppl):4-11
pubmed: 25850120
J Gen Intern Med. 2010 Dec;25(12):1363-9
pubmed: 20697960
J Gen Intern Med. 2007 Sep;22(9):1231-8
pubmed: 17594129